HLA and amyotrophic lateral sclerosis: a systematic review and meta-analysis

References

• Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. World federation of neurology research group on motor neuron D. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMed Web of Science ®Google Scholar
• Fang T, Al Khleifat A, Meurgey J-H, Jones A, Leigh PN, Bensimon G, et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17:416–22.
   PubMed Web of Science ®Google Scholar
• Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012;2012:CD001447.
   PubMedGoogle Scholar
• Chio A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, et al. Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry. 2012;83:377–81.
   PubMed Web of Science ®Google Scholar
• Norris SP, Likanje MN, Andrews JA. Amyotrophic lateral sclerosis: update on clinical management. Curr Opin Neurol. 2020;33:641–8.
   PubMed Web of Science ®Google Scholar
• Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–93.
   PubMed Web of Science ®Google Scholar
• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.
   PubMed Web of Science ®Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
   PubMed Web of Science ®Google Scholar
• Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367–74.
   PubMed Web of Science ®Google Scholar
• Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol. 1990;47:1210–6.
   PubMed Web of Science ®Google Scholar
• Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol. 1993;50:30–6.
   PubMedGoogle Scholar
• McGeer PL, McGeer EG, Kawamata T, Yamada T, Akiyama H. Reactions of the immune system in chronic degenerative neurological diseases. Can J Neurol Sci. 1991;18:376–9.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD. The Role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11:246–54.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020;11:279.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, van der Spek RAA, de Klein N, Westra HJ, Deelen P, Shireby G, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53:1636–48.
   PubMed Web of Science ®Google Scholar
• Choo SY. Immunogenetics of the HLA system. Yonsei Med J. 1991;32:1–8.
   PubMedGoogle Scholar
• Misra MK, Damotte V, Hollenbach JA. The immunogenetics of neurological disease. Immunology 2018;153:399–414.
   PubMed Web of Science ®Google Scholar
• Behan PO, Dick HM, Durward WF. Histocompatibility antigens associated with motor neurone disease. J Neurol Sci. 1977;32:213–7.
   PubMed Web of Science ®Google Scholar
• Antel JP, Arnason BGW, Fuller TC, Lehrich JR. Histocompatibility typing in amyotrophic lateral sclerosis. Arch Neurol. 1976;33:423–5.
   PubMedGoogle Scholar
• Kott E, Livni E, Zamir R, Kuritzky A. Cell-mediated immunity to polio and hla antigens in amyotrophic lateral sclerosis. Neurology 1979;29:1040–4.
   PubMed Web of Science ®Google Scholar
• Bartfeld H, Pollack MS, Cunningham-Rundles S, Donnenfeld H. HLA frequencies in amyotrophic lateral sclerosis. Arch Neurol. 1982;39:270–1.
   PubMedGoogle Scholar
• Norris FH, Terasaki PI, Henderson B. HLA typing in amyotrophic lateral sclerosis. Arch Neurol. 1986;43:7.
   PubMedGoogle Scholar
• Hoffman P, Robbins D, Gibbs C, Carleton Gajdusek D, Garruto R, Terasaki P. Histocompatibility antigens in amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Lancet. 1977;310:717.
   Google Scholar
• Jokelainen M, Tiilikainen A, Lapinleimu K. Polio antibodies and HLA antigens in amyotrophic lateral sclerosis. Tissue Antigens. 1977;10:259–66.
   PubMedGoogle Scholar
• Woo E, Nightingale S, Dick DJ, Walls TJ, French JM, Bates D. A study of histocompatibility antigens in patients with motor neuron disease in the northern region of England. J Neurol Neurosurg Psychiatry. 1986;49:435–7.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.
   PubMed Web of Science ®Google Scholar
• Pedersen L, Platz P, Jersild C, Thomsen M. Hla (SD and LD) in patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci. 1977;31:313–8.
   PubMed Web of Science ®Google Scholar
• Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131:1975–8.
   PubMed Web of Science ®Google Scholar
• Ka S, Lee S, Hong J, Cho Y, Sung J, Kim HN, et al. HLAscan: genotyping of the HLA region using next-generation sequencing data. BMC Bioinformatics. 2017;18:258.
   PubMed Web of Science ®Google Scholar
• Profaizer T, Lazar-Molnar E, Pole A, Delgado JC, Kumanovics A. HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: a comparison. Int J Immunogenet. 2017;44:164–8.
   PubMed Web of Science ®Google Scholar
• Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 2009;54:15–39.
   PubMed Web of Science ®Google Scholar
• Visser AE, Pazoki R, Pulit SL, van Rheenen W, Raaphorst J, van der Kooi AJ, et al. No association between gluten sensitivity and amyotrophic lateral sclerosis. J Neurol. 2017;264:694–700.
   PubMed Web of Science ®Google Scholar
• Yang X, Zheng J, Tian S, Chen Y, An R, Zhao Q, et al. HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort. J Neurol Sci. 2017;373:124–8.
   PubMed Web of Science ®Google Scholar
• Clinical Trials. Amyotrophic lateral sclerosis. 2022. Available at: https://clinicaltrials.gov/ct2/results?cond=Amyotrophic+Lateral+Sclerosis&term=&cntry=&state=&city=&dist=.
   Google Scholar
• Khalid SI, Ampie L, Kelly R, Ladha SS, Dardis C. Immune modulation in the treatment of amyotrophic lateral sclerosis: a review of clinical trials. Front Neurol. 2017;8:486.
   PubMed Web of Science ®Google Scholar
• Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74:1446–54.
   PubMed Web of Science ®Google Scholar
• Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8:888–99.
   PubMed Web of Science ®Google Scholar
• Benyamin B, He J, Zhao Q, Gratten J, Garton F, Leo PJ, et al. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat Commun. 2017;8:611.
   PubMed Web of Science ®Google Scholar
• Iacoangeli A, Lin T, Al Khleifat A, Jones AR, Opie-Martin S, Coleman JRI, et al. Genome-wide meta-analysis finds the ACSL5-ZDHHC6 locus is associated with ALS and links weight loss to the disease genetics. Cell Rep. 2020;33:108323.
   PubMed Web of Science ®Google Scholar
• Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, et al. A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun Biol. 2020;3:526.
   PubMed Web of Science ®Google Scholar
• Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 2018;97:1268–83 e6.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043–8.
   PubMed Web of Science ®Google Scholar
• Howson JMM, Stevens H, Smyth DJ, Walker NM, Chandler KA, Bingley PJ, et al. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes. 2011;60:2635–44.
   PubMed Web of Science ®Google Scholar
• He X, Lu X, Hu J, Xi J, Zhou D, Shang H, et al. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. Eur J Neurol. 2011;18:359–61.
   PubMed Web of Science ®Google Scholar
• Li M, Wang L, Wang W, Qi XL, Tang ZY. Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies. Braz J Med Biol Res. 2014;47:215–22.
   PubMed Web of Science ®Google Scholar
• Praline J, Blasco H, Vourc’h P, Rat V, Gendrot C, Camu W, et al. Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2012;317:58–61.
   PubMed Web of Science ®Google Scholar